Skip to content

Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury

A Randomized Controlled Multi-Center Trial of the Early Application of CRRT in Patients With Severe Sepsis or Septic Shock

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00837057
Enrollment
60
Registered
2009-02-05
Start date
2009-02-28
Completion date
Unknown
Last updated
2009-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Septic Shock, Severe Sepsis

Brief summary

Severe sepsis or septic shock with acute kidney injury shows high mortality in intensive care unit. A few studies have shown CRRT relating the clinical improvement seems to be related to the early initiation of therapy. But there is no consensus for proper time of CRRT may improve the prognosis. The study is a prospective randomized one center trial comparing two treatments in patients suffering from septic shock complicated with acute renal failure admitted to ICU, treated either early by CRRT (35 ml/kg/h) or by conventional RRT.

Interventions

PROCEDUREcrrt

early CRRT (35 ml/kg/h)& acute kidney injury or failure or nearly anuria more than 2hr or late conventional dialysis indication

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Septic shock (Bone criteria) for less than 14D * RIFLE criteria : Injury or Failure or nearly anuria more than 2hr * Age over 18 years * Written informed consent by next of kin.

Exclusion criteria

* Cirrhosis child class C * CRF or ESRD * Too high APACHE II & SOFA score at admission * Age over 80 years * Life expectancy less than 3 months (metastatic cancer - hepatoma, lung ca.)

Design outcomes

Primary

MeasureTime frame
Death from all causes at 28 days after randomisation28 day

Secondary

MeasureTime frame
Death within the in the intensive care unit. Death within 90 days of randomisation. Death prior to hospital discharge. Length of ICU stay. The need for and duration of other organ support90 day

Countries

South Korea

Contacts

Primary Contactsangbum hong, md
sbhong@amc.seoul.kr82-2-3010-3893

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026